Targeting Phage Therapy 2018 – Program 7b
Don’t forget to submit an abstract if you would like to present your research and innovations during Phage & Antibiotic Resistance Congress.
| Day 1 – May 17, 2018 | |
| 07h30 – 9h00 | Registration & Welcoming |
| 08h55 | Welcome Address |
|
09h00 – 09h20 |
General Introduction: |
| 09h20 – 10h40 |
Session 1: Phage Therapy 2018: recent advances & challenges (part 1) Fighting multi-drug resistant Klebsiella pneumoniae by using lytic phages Control of catheter associated biofilms through efflux inhibition Impact of virulent bacteriophages on vibrio cholerae infection and their use in preventing cholera |
| 10h40 – 11h20 | Coffee Break & Poster Session |
| 11h20 – 12h40 |
Session 1: Phage Therapy 2018: recent advances & challenges (part 2) Phage therapy of infectious biofilms Lytic bacteriophages in the treatment of biofilm-forming bacteria involved in prosthetic joint infections Microencapsulation of purified bacteriophages for targeted therapeutic applications Direct phenotypic screening to identify new antimicrobial agents |
|
|
|
| 12h40 – 14h00 | Lunch Break & Poster Session |
|
|
|
| 14h00 – 15h30 |
Session 1: Phage Therapy 2018: recent advances & challenges (part 3) Development of infection-responsive surface coatings for bacteriophage delivery in the catheterised urinary tract Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection |
| 14h40 – 15h30 |
Call for Short Oral Presentations Among presentations already accepted: Selection and characterisation of phages able to degrade biofilm produced by clinical isolates of E.faecalis State-of-the-art of modeling in vivo dynamics of naturally-occurring phages and in vivo dynamics of therapeutic phages Bacteriophage therapy and urinary tract infections Safe & active sustained release of phages in gastro-intestinal tract Mycobacteriophage based platforms to discover drug targets for mycobacteria Efficient in vivo phage therapy via immunological cloaking |
| 15h30 – 16h15 | Coffee Break & Poster Session |
|
|
|
| 16h15 – 17h00 | Call for Short Oral Presentations |
| 18h30 | End of the first day |
| 20h00 |
Targeting Phage & Antibiotic Resistance Dinner To participate, please register online before May 2nd. |
| Day 2 – May 18, 2018 | |
| 08h55 | Opening of the second day |
| 09h00 – 10h30 |
Session 2: Innovations against antibiotic resistance (part 1) Focus on the new generation of antibiotics Focus on the strategic role of microbiota to overcome antibiotic resistance Antimicrobial discovery from extreme halophiles General overview on the transmission of multidrug-resistant Mycobacterium tuberculosis Microarray patches for prevention and treatment of infectious diseases and their potential for reducing antibiotic resistance |
| 10h30 – 11h00 | Coffee Break & Poster Session |
| 11h00 – 12h00 | Session 2: Innovations against antibiotic resistance (part 2) |
| 12h00 – 12h45 |
Reincarnation of a staphylococcal pathogenicity island as an antibacterial drone Call for Short Oral Presentations Inhibition of Shikimate kinase from M. Tuberculosis and H. Pylori for antibiotic discovery |
|
|
|
| 12h45 – 14h00 | Lunch Break & Poster Session |
|
|
|
|
14h00 – 15h30 |
Session 3: Special Session for Industrials: Innovations & Perspectives This session is dedicated only to industrials, pharma companies, biotech and start-ups, to showcase their innovations. Phage-based antimicrobials: novel approaches for managing drug-resistant bacteria Novel phage based therapeutics to address antibiotic resistance Call for Short Oral Presentations |
| 15h30 – 16h00 | Coffee Break & Poster Session |
| 16h00 – 17h00 | Call for Short Oral Presentations |
| 17h00 – 17h45 | Round Table Discussion & Concluding Remarks |
| 17h45 – 18h00 |
Targeting Phage & Antibiotic Resistance Awards |
| 18h00 | End of Targeting Phage & Antibiotic Resistance 2018 |